PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 153 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2016. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $27,667,000 | -12.7% | 564,579 | -12.1% | 0.72% | -18.4% |
| Q1 2018 | $31,700,000 | -54.5% | 642,179 | -20.1% | 0.89% | -61.5% |
| Q4 2017 | $69,628,000 | -68.5% | 803,820 | -56.5% | 2.31% | -45.4% |
| Q3 2017 | $221,254,000 | +245.2% | 1,847,640 | +152.0% | 4.22% | +31.0% |
| Q2 2017 | $64,092,000 | +28385.3% | 733,320 | +9885.3% | 3.22% | +20056.2% |
| Q4 2016 | $225,000 | -54.3% | 7,344 | 0.0% | 0.02% | -50.0% |
| Q3 2016 | $492,000 | -95.8% | 7,344 | -92.7% | 0.03% | -95.4% |
| Q2 2015 | $11,675,000 | +344.9% | 100,000 | +809.1% | 0.70% | +149.3% |
| Q3 2014 | $2,624,000 | +3352.6% | 11,000 | +1396.6% | 0.28% | +3425.0% |
| Q1 2014 | $76,000 | 0.0% | 735 | 0.0% | 0.01% | -11.1% |
| Q4 2013 | $76,000 | – | 735 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,300,000 | $12,636,000 | 2.61% |
| AIGH Capital Management LLC | 964,590 | $9,376,000 | 1.97% |
| Worth Venture Partners, LLC | 226,758 | $2,204,000 | 1.07% |
| Camber Capital Management LP | 2,555,000 | $24,835,000 | 0.85% |
| Palo Alto Investors LP | 1,392,997 | $13,540,000 | 0.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,769,795 | $36,642,000 | 0.77% |
| GLOBEFLEX CAPITAL L P | 428,680 | $4,167,000 | 0.76% |
| Zebra Capital Management LLC | 34,243 | $333,000 | 0.37% |
| Sofinnova Investments, Inc. | 344,917 | $3,353,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 605,792 | $5,888,000 | 0.19% |